Use of the Decipher genomic classifier among men with prostate cancer in the United States

BACKGROUND: Management of localized or recurrent prostate cancer since the 1990s has been based on risk stratification using clinicopathological variables, including Gleason score, T stage (based on digital rectal exam), and prostate-specific antigen (PSA). In this study a novel prognostic test, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaorsky, Nicholas G, Proudfoot, James A, Jia, Angela Y, Zuhour, Raed, Vince Jr, Randy, Liu, Yang, Zhao, Xin, Hu, Jim, Schussler, Nicola C, Stevens, Jennifer L, Bentler, Suzanne, Cress, Rosemary D, Doherty, Jennifer A, Durbin, Eric B, Gershman, Susan, Cheng, Iona, Gonsalves, Lou, Hernandez, Brenda Y, Liu, Lihua, Morawski, Bożena M, Schymura, Maria, Schwartz, Stephen M, Ward, Kevin C, Wiggins, Charles, Wu, Xiao-Cheng, Shoag, Jonathan E, Ponsky, Lee, Dal Pra, Alan, Schaeffer, Edward M, Ross, Ashley E, Sun, Yilun, Davicioni, Elai, Petkov, Valentina, Spratt, Daniel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505256/
https://www.ncbi.nlm.nih.gov/pubmed/37525535
http://dx.doi.org/10.1093/jncics/pkad052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505256/
https://www.ncbi.nlm.nih.gov/pubmed/37525535
http://dx.doi.org/10.1093/jncics/pkad052

Ejemplares similares